4.6 Article

Seeking Safety treatment for male veterans with a substance use disorder and post-traumatic stress disorder symptomatology

期刊

ADDICTION
卷 107, 期 3, 页码 578-586

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1360-0443.2011.03658.x

关键词

Dual diagnosis; post-traumatic stress disorder; PTSD; seeking safety; substance abuse; substance use disorder; therapy

资金

  1. VA Health Services Research and Development Service [IIR 04-175-3]

向作者/读者索取更多资源

Aims To determine whether substituting Seeking Safety (SS), a manualized therapy for comorbid substance use disorders (SUD) and post-traumatic stress disorder (PTSD) for part of treatment-as-usual (TAU) improves substance use outcomes. Design Randomized controlled effectiveness trial. Settings Out-patient Veterans Administration Health Care System SUD clinic. Participants Ninety-eight male military Veterans with a SUD and co-occurring PTSD symptomatology. Measurements Drug and alcohol use and PTSD severity, measured on the first day of treatment, and 3 (i.e. the planned end of SS sessions) and 6 months following the baseline assessment. Treatment attendance and patient satisfactionwere measured following treatment (3-month follow-up). Active copingwas measured at treatment intake and following treatment. Findings SS compared to TAU was associated with better drug use outcomes (P < 0.05), but alcohol use and PTSD severity decreased equally under both treatments (P's < 0.01). SS versusTAUwas associated with increased treatment attendance, client satisfaction and active coping (all P's < 0.01). However, neither these factors nor decreases in PTSD severity mediated the effect of treatment on drug use. Conclusions The manualized treatment approach for substance use disorder, Seeking Safety, is well received and associated with better drug use outcomes than ` treatment as usual' in male veterans with post-traumatic stress disorder. However, the mechanism of its effect is unclear.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据